Clinical trial
O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
NCT00004072 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004072 |
|---|---|
| Title | O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma |
| Official title | Phase II Trial of O6-Benzylguanine (NSC 637037) and BCNU in Patients With Multiple Myeloma |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug |
| Interventions | O6-benzylguanine, carmustine |
| Enrollment | 17 |
| Start date | Sep 1, 1999 |
| Primary completion | Aug 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: